Skip to main content
https://pbs.twimg.com/media/F2ocAmTWcAIN46V.jpg
Tofacitinib in Polymyalgia Rheumatica (EAST PMR Study) An open-label, uncontrolled pilot trial has shown that JAK signaling is involved in the pathogenesis of PMR and that tofacitinib is as effective as glucocorticoids (GC) in patients with PMR. https://t.co/sJcq9lMP1l https://t.co/zvmPs3SdCw
Dr. John Cush
03-08-2023
×